{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T06:11:52Z","timestamp":1793513512046,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,20]]},"DOI":"10.7759\/cureus.28201","type":"journal-article","created":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T14:20:14Z","timestamp":1661005214000},"source":"Crossref","is-referenced-by-count":36,"title":["Hypothyroidism and Depression: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Surya P","family":"Nuguru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sriker","family":"Rachakonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shravani","family":"Sripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mashal I","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roja T","family":"Meda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1994.03950010008002","article-title":"Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey","volume":"51","author":"Kessler RC","year":"1994","unstructured":"Kessler RC, McGonagle KA, Zhao S, et al.. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994, 51:8-19. 10.1001\/archpsyc.1994.03950010008002","journal-title":"Arch Gen Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.46.1.37","article-title":"Borderline hypothyroidism and depression","volume":"46","author":"Haggerty JJ Jr","year":"1995","unstructured":"Haggerty JJ Jr, Prange AJ Jr. Borderline hypothyroidism and depression. Annu Rev Med. 1995, 46:37-46. 10.1146\/annurev.med.46.1.37","journal-title":"Annu Rev Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.IJEM_265_17","article-title":"Hypothyroidism and depression: are cytokines the link?","volume":"21","author":"Tayde PS","year":"2017","unstructured":"Tayde PS, Bhagwat NM, Sharma P, et al.. Hypothyroidism and depression: are cytokines the link?. Indian J Endocrinol Metab. 2017, 21:886-92. 10.4103\/ijem.IJEM_265_17","journal-title":"Indian J Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ph15040391","article-title":"Depression and autoimmune hypothyroidism-their relationship and the effects of treating psychiatric and thyroid disorders on changes in clinical and biochemical parameters including bdnf and other cytokines - a systematic review","volume":"15","author":"Kotkowska Z","year":"2022","unstructured":"Kotkowska Z, Strzelecki D. Depression and autoimmune hypothyroidism-their relationship and the effects of treating psychiatric and thyroid disorders on changes in clinical and biochemical parameters including bdnf and other cytokines - a systematic review. Pharmaceuticals (Basel). 2022, 15:10.3390\/ph15040391","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1995.tb00540.x","article-title":"Neuroendocrine evidence for an association between hypothyroidism, reduced central 5-HT activity and depression","volume":"43","author":"Cleare AJ","year":"1995","unstructured":"Cleare AJ, McGregor A, O'Keane V. Neuroendocrine evidence for an association between hypothyroidism, reduced central 5-HT activity and depression. Clin Endocrinol (Oxf). 1995, 43:713-9. 10.1111\/j.1365-2265.1995.tb00540.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2007.11.020","article-title":"Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder","volume":"63","author":"Iosifescu DV","year":"2008","unstructured":"Iosifescu DV, Bolo NR, Nierenberg AA, Jensen JE, Fava M, Renshaw PF. Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder. Biol Psychiatry. 2008, 63:1127-34. 10.1016\/j.biopsych.2007.11.020","journal-title":"Biol Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.pscychresns.2009.07.001","article-title":"Regional cerebral glucose metabolism and anxiety symptoms in bipolar depression: effects of levothyroxine","volume":"181","author":"Bauer M","year":"2010","unstructured":"Bauer M, Berman SM, Schlagenhauf F, et al.. Regional cerebral glucose metabolism and anxiety symptoms in bipolar depression: effects of levothyroxine. Psychiatry Res. 2010, 181:71-6. 10.1016\/j.pscychresns.2009.07.001","journal-title":"Psychiatry Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2005.03.003","article-title":"The stress system in the human brain in depression and neurodegeneration","volume":"4","author":"Swaab DF","year":"2005","unstructured":"Swaab DF, Bao AM, Lucassen PJ. The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev. 2005, 4:141-94. 10.1016\/j.arr.2005.03.003","journal-title":"Ageing Res Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2018.18","article-title":"Global epidemiology of hyperthyroidism and hypothyroidism","volume":"14","author":"Taylor PN","year":"2018","unstructured":"Taylor PN, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus JH, Dayan CM, Okosieme OE. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol. 2018, 14:301-16. 10.1038\/nrendo.2018.18","journal-title":"Nat Rev Endocrinol"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.4158\/1934-2403-8.6.457","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism","volume":"8","author":"Baskin HJ","year":"2002","unstructured":"Baskin HJ, Cobin RH, Duick DS, Gharib H, Guttler RB, Kaplan MM, Segal RL. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract. 2002, 8:457-69.","journal-title":"Endocr Pract"},{"key":"ref11","article-title":"Neurological and psychiatric disorders in thyroid dysfunctions. The role of nuclear medicine: SPECT and PET imaging","volume":"33","author":"Lass P","year":"2008","unstructured":"Lass P, Slawek J, Derejko M, Rubello D. Neurological and psychiatric disorders in thyroid dysfunctions. The role of nuclear medicine: SPECT and PET imaging. Minerva Endocrinol. 2008, 33:75-84.","journal-title":"Minerva Endocrinol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/590648","article-title":"The link between thyroid function and depression","volume":"2012","author":"Hage MP","year":"2012","unstructured":"Hage MP, Azar ST. The link between thyroid function and depression. J Thyroid Res. 2012, 2012:590648. 10.1155\/2012\/590648","journal-title":"J Thyroid Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-2-1-87","article-title":"Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications","volume":"2","author":"Larsen PR","year":"1981","unstructured":"Larsen PR, Silva JE, Kaplan MM. Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications. Endocr Rev. 1981, 2:87-102. 10.1210\/edrv-2-1-87","journal-title":"Endocr Rev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1210\/endo-117-3-1201","article-title":"Concentrations of thyroxine and 3,5,3'-triiodothyronine at 34 different sites in euthyroid rats as determined by an isotopic equilibrium technique","volume":"117","author":"van Doorn J","year":"1985","unstructured":"van Doorn J, Roelfsema F, van der Heide D. Concentrations of thyroxine and 3,5,3'-triiodothyronine at 34 different sites in euthyroid rats as determined by an isotopic equilibrium technique. Endocrinology. 1985, 117:1201-8. 10.1210\/endo-117-3-1201","journal-title":"Endocrinology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1983.01790040063009","article-title":"CSF somatostatin in affective illness","volume":"40","author":"Rubinow DR","year":"1983","unstructured":"Rubinow DR, Gold PW, Post RM, Ballenger JC, Cowdry R, Bollinger J, Reichlin S. CSF somatostatin in affective illness. Arch Gen Psychiatry. 1983, 40:409-12. 10.1001\/archpsyc.1983.01790040063009","journal-title":"Arch Gen Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1986.01800120034008","article-title":"Alterations in cerebrospinal fluid concentrations of somatostatinlike immunoreactivity in neuropsychiatric disorders","volume":"43","author":"Bissette G","year":"1986","unstructured":"Bissette G, Widerl\u00f6v E, Wall\u00e9us H, Karlsson I, Eklund K, Forsman A, Nemeroff CB. Alterations in cerebrospinal fluid concentrations of somatostatinlike immunoreactivity in neuropsychiatric disorders. Arch Gen Psychiatry. 1986, 43:1148-51. 10.1001\/archpsyc.1986.01800120034008","journal-title":"Arch Gen Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1380001","article-title":"The role of thyroid hormones in depression","volume":"138","author":"Kirkegaard C","year":"1998","unstructured":"Kirkegaard C, Faber J. The role of thyroid hormones in depression. Eur J Endocrinol. 1998, 138:1-9. 10.1530\/eje.0.1380001","journal-title":"Eur J Endocrinol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s42000-021-00312-3","article-title":"Subclinical thyroid dysfunction and major depressive disorder","volume":"20","author":"Karakatsoulis GN","year":"2021","unstructured":"Karakatsoulis GN, Tsapakis EM, Mitkani C, Fountoulakis KN. Subclinical thyroid dysfunction and major depressive disorder. Hormones (Athens). 2021, 20:613-21. 10.1007\/s42000-021-00312-3","journal-title":"Hormones (Athens)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2019.08.067","article-title":"Association of thyroid dysfunction with suicide attempts in first-episode and drug na\u00efve patients with major depressive disorder","volume":"259","author":"Shen Y","year":"2019","unstructured":"Shen Y, Wu F, Zhou Y, et al.. Association of thyroid dysfunction with suicide attempts in first-episode and drug na\u00efve patients with major depressive disorder. J Affect Disord. 2019, 259:180-5. 10.1016\/j.jad.2019.08.067","journal-title":"J Affect Disord"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4530(79)90006-4","article-title":"Increased levels of TRH in cerebrospinal fluid from patients with endogenous depression","volume":"4","author":"Kirkegaard C","year":"1979","unstructured":"Kirkegaard C, Faber J, Hummer L, Rogowski P. Increased levels of TRH in cerebrospinal fluid from patients with endogenous depression. Psychoneuroendocrinology. 1979, 4:227-235. 10.1016\/0306-4530(79)90006-4","journal-title":"Psychoneuroendocrinology"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1080\/15622970500474739","article-title":"Peripheral thyroid dysfunction in depression","volume":"7","author":"Fountoulakis KN","year":"2006","unstructured":"Fountoulakis KN, Kantartzis S, Siamouli M, Panagiotidis P, Kaprinis S, Iacovides A, Kaprinis G. Peripheral thyroid dysfunction in depression. World J Biol Psychiatry. 2006, 7:131-7. 10.1080\/15622970500474739","journal-title":"World J Biol Psychiatry"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/0163-8343(90)90060-p","article-title":"Review: thyroid function in psychiatric illness","volume":"12","author":"Hein MD","year":"1990","unstructured":"Hein MD, Jackson IM. Review: thyroid function in psychiatric illness. Gen Hosp Psychiatry. 1990, 12:232-244. 10.1016\/0163-8343(90)90060-p","journal-title":"Gen Hosp Psychiatry"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00276","article-title":"Subclinical hypothyroidism and depression: is there a link?","volume":"103","author":"Samuels MH","year":"2018","unstructured":"Samuels MH. Subclinical hypothyroidism and depression: is there a link?. J Clin Endocrinol Metab. 2018, 103:2061-4. 10.1210\/jc.2018-00276","journal-title":"J Clin Endocrinol Metab"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4183\/aeb.2020.256","article-title":"Thyroid hormones as a third line of augmentation medication in treatment-resistant depression","volume":"16","author":"Trifu S","year":"2020","unstructured":"Trifu S, Popescu A, Dragoi AM, Trifu AI. Thyroid hormones as a third line of augmentation medication in treatment-resistant depression. Acta Endocrinol (Buchar). 2020, 16:256-61. 10.4183\/aeb.2020.256","journal-title":"Acta Endocrinol (Buchar)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1515\/med-2019-0008","article-title":"The link between thyroid autoimmunity, depression and bipolar disorder","volume":"14","author":"Jucevi\u010di\u016bt\u0117 N","year":"2019","unstructured":"Jucevi\u010di\u016bt\u0117 N, \u017dilaitien\u0117 B, Aniulien\u0117 R, Vanagien\u0117 V. The link between thyroid autoimmunity, depression and bipolar disorder. Open Med (Wars). 2019, 14:52-8. 10.1515\/med-2019-0008","journal-title":"Open Med (Wars)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000089","article-title":"Psychiatric and cognitive manifestations of hypothyroidism","volume":"21","author":"Samuels MH","year":"2014","unstructured":"Samuels MH. Psychiatric and cognitive manifestations of hypothyroidism. Curr Opin Endocrinol Diabetes Obes. 2014, 21:377-83. 10.1097\/MED.0000000000000089","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2826.2008.01774.x","article-title":"The thyroid-brain interaction in thyroid disorders and mood disorders","volume":"20","author":"Bauer M","year":"2008","unstructured":"Bauer M, Goetz T, Glenn T, Whybrow PC. The thyroid-brain interaction in thyroid disorders and mood disorders. J Neuroendocrinol. 2008, 20:1101-14. 10.1111\/j.1365-2826.2008.01774.x","journal-title":"J Neuroendocrinol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2015.05.005","article-title":"Chronobiological hypothalamic-pituitary-thyroid axis status and antidepressant outcome in major depression","volume":"59","author":"Duval F","year":"2015","unstructured":"Duval F, Mokrani MC, Erb A, Gonzalez Lopera F, Alexa C, Proudnikova X, Butucaru I. Chronobiological hypothalamic-pituitary-thyroid axis status and antidepressant outcome in major depression. Psychoneuroendocrinology. 2015, 59:71-80. 10.1016\/j.psyneuen.2015.05.005","journal-title":"Psychoneuroendocrinology"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1997.tb09648.x","article-title":"The hypothalamic-pituitary-thyroid axis in major depression","volume":"95","author":"Sullivan PF","year":"1997","unstructured":"Sullivan PF, Wilson DA, Mulder RT, Joyce PR. The hypothalamic-pituitary-thyroid axis in major depression. Acta Psychiatr Scand. 1997, 95:370-8. 10.1111\/j.1600-0447.1997.tb09648.x","journal-title":"Acta Psychiatr Scand"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2019.11.004","article-title":"Prevalence and clinical correlates of subclinical hypothyroidism in first-episode drug-naive patients with major depressive disorder in a large sample of Chinese","volume":"263","author":"Lang X","year":"2020","unstructured":"Lang X, Hou X, Shangguan F, Zhang XY. Prevalence and clinical correlates of subclinical hypothyroidism in first-episode drug-naive patients with major depressive disorder in a large sample of Chinese. J Affect Disord. 2020, 263:507-15. 10.1016\/j.jad.2019.11.004","journal-title":"J Affect Disord"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s00127-015-1043-0","article-title":"Diagnosed thyroid disorders are associated with depression and anxiety","volume":"50","author":"Ittermann T","year":"2015","unstructured":"Ittermann T, V\u00f6lzke H, Baumeister SE, Appel K, Grabe HJ. Diagnosed thyroid disorders are associated with depression and anxiety. Soc Psychiatry Psychiatr Epidemiol. 2015, 50:1417-25. 10.1007\/s00127-015-1043-0","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_456_19","article-title":"Prevalence of depression among hypothyroid patients attending the primary healthcare and endocrine clinics of King Fahad Hospital of the University (KFHU)","volume":"8","author":"Mohammad MY","year":"2019","unstructured":"Mohammad MY, Bushulaybi NA, AlHumam AS, AlGhamdi AY, Aldakhil HA, Alumair NA, Shafey MM. Prevalence of depression among hypothyroid patients attending the primary healthcare and endocrine clinics of King Fahad Hospital of the University (KFHU). J Family Med Prim Care. 2019, 8:2708-13. 10.4103\/jfmpc.jfmpc_456_19","journal-title":"J Family Med Prim Care"},{"key":"ref33","article-title":"Prevalence of depression in patients affected by subclinical hypothyroidism","volume":"52","author":"Demartini B","year":"2010","unstructured":"Demartini B, Masu A, Scarone S, Pontiroli AE, Gambini O. Prevalence of depression in patients affected by subclinical hypothyroidism. Panminerva Med. 2010, 52:277-82.","journal-title":"Panminerva Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-018-2006-2","article-title":"Association between subclinical hypothyroidism and depression: an updated systematic review and meta-analysis","volume":"19","author":"Loh HH","year":"2019","unstructured":"Loh HH, Lim LL, Yee A, Loh HS. Association between subclinical hypothyroidism and depression: an updated systematic review and meta-analysis. BMC Psychiatry. 2019, 19:12. 10.1186\/s12888-018-2006-2","journal-title":"BMC Psychiatry"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02449-4","article-title":"Correlation between TSH levels and quality of life among subjects with well-controlled primary hypothyroidism","volume":"72","author":"Mor\u00f3n-D\u00edaz M","year":"2021","unstructured":"Mor\u00f3n-D\u00edaz M, Saavedra P, Alberiche-Ruano MP, et al.. Correlation between TSH levels and quality of life among subjects with well-controlled primary hypothyroidism. Endocrine. 2021, 72:190-7. 10.1007\/s12020-020-02449-4","journal-title":"Endocrine"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.IJEM_702_17","article-title":"Impairment of health-related quality of life among Indian patients with hypothyroidism","volume":"22","author":"Shivaprasad C","year":"2018","unstructured":"Shivaprasad C, Rakesh B, Anish K, Annie P, Amit G, Dwarakanath CS. Impairment of health-related quality of life among Indian patients with hypothyroidism. Indian J Endocrinol Metab. 2018, 22:335-8. 10.4103\/ijem.IJEM_702_17","journal-title":"Indian J Endocrinol Metab"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156925","article-title":"Disease-specific as well as generic quality of life is widely impacted in autoimmune hypothyroidism and improves during the first six months of levothyroxine therapy","volume":"11","author":"Winther KH","year":"2016","unstructured":"Winther KH, Cramon P, Watt T, et al.. Disease-specific as well as generic quality of life is widely impacted in autoimmune hypothyroidism and improves during the first six months of levothyroxine therapy. PLoS One. 2016, 11:e0156925. 10.1371\/journal.pone.0156925","journal-title":"PLoS One"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmy064","article-title":"Patients on levothyroxine replacement in the community: association between hypothyroidism symptoms, co-morbidities and their quality of life","volume":"36","author":"Tan NC","year":"2019","unstructured":"Tan NC, Chew RQ, Subramanian RC, Sankari U, Koh YL, Cho LW. Patients on levothyroxine replacement in the community: association between hypothyroidism symptoms, co-morbidities and their quality of life. Fam Pract. 2019, 36:269-75. 10.1093\/fampra\/cmy064","journal-title":"Fam Pract"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2014.0028","article-title":"Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement","volume":"24","author":"Jonklaas J","year":"2014","unstructured":"Jonklaas J, Bianco AC, Bauer AJ, et al.. Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid. 2014, 24:1670-751. 10.1089\/thy.2014.0028","journal-title":"Thyroid"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1159\/000356507","article-title":"2013 ETA guideline: management of subclinical hypothyroidism","volume":"2","author":"Pearce SH","year":"2013","unstructured":"Pearce SH, Brabant G, Duntas LH, Monzani F, Peeters RP, Razvi S, Wemeau JL. 2013 ETA guideline: management of subclinical hypothyroidism. Eur Thyroid J. 2013, 2:215-28. 10.1159\/000356507","journal-title":"Eur Thyroid J"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.15.1714","article-title":"The starting dose of levothyroxine in primary hypothyroidism treatment: a prospective, randomized, double-blind trial","volume":"165","author":"Roos A","year":"2005","unstructured":"Roos A, Linn-Rasker SP, van Domburg RT, Tijssen JP, Berghout A. The starting dose of levothyroxine in primary hypothyroidism treatment: a prospective, randomized, double-blind trial. Arch Intern Med. 2005, 165:1714-20. 10.1001\/archinte.165.15.1714","journal-title":"Arch Intern Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12538","article-title":"Defending plasma T3 is a biological priority","volume":"81","author":"Abdalla SM","year":"2014","unstructured":"Abdalla SM, Bianco AC. Defending plasma T3 is a biological priority. Clin Endocrinol (Oxf). 2014, 81:633-41. 10.1111\/cen.12538","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14189","article-title":"Effect of increased levothyroxine dose on depressive mood in older adults undergoing thyroid hormone replacement therapy","volume":"93","author":"Moon JH","year":"2020","unstructured":"Moon JH, Han JW, Oh TJ, Choi SH, Lim S, Kim KW, Jang HC. Effect of increased levothyroxine dose on depressive mood in older adults undergoing thyroid hormone replacement therapy. Clin Endocrinol (Oxf). 2020, 93:196-203. 10.1111\/cen.14189","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2017.01.005","article-title":"The effect of l-thyroxine treatment on sexual function and depressive symptoms in men with autoimmune hypothyroidism","volume":"69","author":"Krysiak R","year":"2017","unstructured":"Krysiak R, Szkr\u00f3bka W, Okopie\u0144 B. The effect of l-thyroxine treatment on sexual function and depressive symptoms in men with autoimmune hypothyroidism. Pharmacol Rep. 2017, 69:432-7. 10.1016\/j.pharep.2017.01.005","journal-title":"Pharmacol Rep"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2013.12.004","article-title":"Low mood and response to Levothyroxine treatment in Indian patients with subclinical hypothyroidism","volume":"8","author":"Vishnoi G","year":"2014","unstructured":"Vishnoi G, Chakraborty B, Garda H, Gowda SH, Goswami B. Low mood and response to Levothyroxine treatment in Indian patients with subclinical hypothyroidism. Asian J Psychiatr. 2014, 8:89-93. 10.1016\/j.ajp.2013.12.004","journal-title":"Asian J Psychiatr"},{"key":"ref46","article-title":"[Should depressive symptoms in patients with subclinical hypothyroidism be treated with thyroid hormone?]","volume":"50","author":"van Harten AC","year":"2008","unstructured":"van Harten AC, Leue C, Verhey FR. [Should depressive symptoms in patients with subclinical hypothyroidism be treated with thyroid hormone?]. Tijdschr Psychiatr. 2008, 50:539-43.","journal-title":"Tijdschr Psychiatr"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4000963","article-title":"Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain","volume":"7","author":"Bauer M","year":"2002","unstructured":"Bauer M, Heinz A, Whybrow PC. Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain. Mol Psychiatry. 2002, 7:140-56. 10.1038\/sj.mp.4000963","journal-title":"Mol Psychiatry"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1996.6.537","article-title":"Novel uses of thyroid hormones in patients with affective disorders","volume":"6","author":"Prange AJ Jr","year":"1996","unstructured":"Prange AJ Jr. Novel uses of thyroid hormones in patients with affective disorders. Thyroid. 1996, 6:537-43. 10.1089\/thy.1996.6.537","journal-title":"Thyroid"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.10.1617","article-title":"Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature","volume":"158","author":"Altshuler LL","year":"2001","unstructured":"Altshuler LL, Bauer M, Frye MA, et al.. Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature. Am J Psychiatry. 2001, 158:1617-22. 10.1176\/appi.ajp.158.10.1617","journal-title":"Am J Psychiatry"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.64.6.679","article-title":"Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial","volume":"64","author":"Cooper-Kazaz R","year":"2007","unstructured":"Cooper-Kazaz R, Apter JT, Cohen R, et al.. Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry. 2007, 64:679-88. 10.1001\/archpsyc.64.6.679","journal-title":"Arch Gen Psychiatry"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(02)00320-2","article-title":"Supraphysiological doses of l-thyroxine in the maintenance treatment of prophylaxis-resistant affective disorders","volume":"27","author":"Bauer M","year":"2002","unstructured":"Bauer M, Bergh\u00f6fer A, Bschor T, et al.. Supraphysiological doses of l-thyroxine in the maintenance treatment of prophylaxis-resistant affective disorders. Neuropsychopharmacology. 2002, 27:620-8. 10.1016\/S0893-133X(02)00320-2","journal-title":"Neuropsychopharmacology"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001647","article-title":"Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression","volume":"10","author":"Bauer M","year":"2005","unstructured":"Bauer M, London ED, Rasgon N, et al.. Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression. Mol Psychiatry. 2005, 10:456-69. 10.1038\/sj.mp.4001647","journal-title":"Mol Psychiatry"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(97)00181-4","article-title":"Treatment of refractory depression with high-dose thyroxine","volume":"18","author":"Bauer M","year":"1998","unstructured":"Bauer M, Hellweg R, Gr\u00e4f KJ, Baumgartner A. Treatment of refractory depression with high-dose thyroxine. Neuropsychopharmacology. 1998, 18:444-55. 10.1016\/S0893-133X(97)00181-4","journal-title":"Neuropsychopharmacology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/108113-hypothyroidism-and-depression-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:38:38Z","timestamp":1707507518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/108113-hypothyroidism-and-depression-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,20]]},"references-count":53,"URL":"https:\/\/doi.org\/10.7759\/cureus.28201","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,20]]}}}